- US-listed companies
- GRI Bio, Inc.
- Income statement
GRI Bio, Inc. (GRI) Income statement
Market cap
$194.94K
P/E ratio
| 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Research & development | 5 | 1 | 3 | 4 |
| Operating expenses | 9 | 7 | 11 | 8 |
| Operating income | -9 | -7 | -11 | -8 |
| Net income | -9 | -7 | -13 | -8 |
| Earnings per share | -1.42 | -0.69 | -28.25 | -55.21 |
| Diluted EPS | -1.42 | -0.69 | -28.25 | -55.21 |